Pharmacists in Old Town, Maine


13 Pharmacists found in Old Town
female pharmacist

Alexandria Durland, PHARMD, BSHS


Pharmacist
302 Main St, Old Town, ME 04468
207-827-8021    

male pharmacist

Bradley Bouchard


Pharmacist
302 Main St, Old Town, ME 04468
207-827-8021    

female pharmacist

Chandra Mae Rogers


Pharmacist
500 Stillwater Ave, Old Town, ME 04468
207-872-3950     207-872-3953



male pharmacist

Jan Louis Booysen


Pharmacist
302 Main St, Old Town, ME 04468
207-827-8021     207-827-3829

male pharmacist

Mr. Johannes Dawid Van Der Merwe, R.PH.


Pharmacist
302 Main St, Old Town, ME 04468
207-827-8021     207-827-3829

male pharmacist

Jonathan Roy


Pharmacist
500 Stillwater Ave, Old Town, ME 04468
207-827-3950     207-827-3953

female pharmacist

Dr. Karolina Anna Mandes, PHARM D


Pharmacist
302 Main St, Old Town, ME 04468
207-827-8021    

female pharmacist

Kelly Gehman, PHARMD


Pharmacist
500 Stillwater Ave, Old Town, ME 04468
207-827-3950     207-827-3953

male pharmacist

Michael D Warmuth, RPH.


Pharmacist
242 Brunswick St, Old Town, ME 04468
207-827-6128     207-827-5533

female pharmacist

Terri Underhill Mclaughlin, PHARMD


Pharmacist
500 Stillwater Ave, Old Town, ME 04468
207-827-3950     207-827-3953

female pharmacist

Tessa T Nguyen, PHARM.D


Pharmacist
302 Main St, Old Town, ME 04468
207-827-8021    

female pharmacist

Mrs. Vanita Kini


Pharmacist
302 Main St, Old Town, ME 04468
207-827-8021     207-827-3829

female pharmacist

Yulia Grindle


Pharmacist
302 Main St, Old Town, ME 04468
207-827-8021    


Type of Pharmacists:
Psychiatric Pharmacist: A licensed pharmacist who has demonstrated specialized knowledge and skill in optimizing care of patients with psychiatric illness by assessing and monitoring patients, recognizing drug-induced problems, and recommending appropriate treatment plans.
Oncology Pharmacist: A licensed pharmacist who has demonstrated specialized knowledge and skill in developing, recommending, implementing, monitoring, and modifying pharmacotherapeutic plans to optimize outcomes in patients with malignant diseases.